DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20205091

Azithromycin and ceftriaxone in uncomplicated typhoid fever in paediatric patients: a prospective, comparative and randomized open labelled trail

K. Narayan Rao, R. Pratyusha, Anand Acharya

Abstract


Background: Typhoid fever is a life-threatening infection caused by the bacterium Salmonella typhi. There are limited options for treatment of typhoid fever in children. Carbapenems and azithromycin are two drugs which is available for treatment of infection caused by extensively drug-resistant (XDR) strain of Salmonella typhi.

Methods: This is a prospective, comparative, randomized open labelled trail conducted in the department of paediatrics Konaseema institute of medical science, Amalapuram, Andhra Pradesh. Blood sample was obtained from each patient before start of treatment for determination of complete blood count and differential count at baseline. Everyday each patient was evaluated clinically.

Results: The mean duration of fever after start of treatment was 4.41.46 days in group treated by azithromycin and 3.95+1.02 days in group treated by ceftriaxone which is little early without  statistical significance.

Conclusions: From present study we can conclude that azithromycin 20 mg/kg/day is as effective as ceftriaxone 75 mg/kg/day for the treatment of typhoid fever in children. Clinical and microbiological cure was comparable in both groups. There was no incidence of relapse of fever in azithromycin treatment group. Diarrhoea was common in patients treated with ceftriaxone and nausea and vomiting was more common in patient treated with azithromycin.


Keywords


Typhoid fever, Azithromycin, Ceftriaxone

Full Text:

PDF

References


Key facts, Typhoid. World health organisation. 2018. Available at: https://www.who.int/news-room/fact-sheets/detail/typhoid. Accessed on: 25 September 2020.

Rosove L, Chudnoff JS, Bower AG. Chloramphenicol in the treatment of typhoid fever. Calif Med. 1950;72(6):425-30.

Zaki SA, Karande S. Multidrug-resistant typhoid fever: a review. J Infect Dev Ctries. 2011;5(5):324-37.

Christopher PM, Isabela R, Kamini W, Priscilla R, Stephen B, Buddha B, et al. Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities BMJ 2019; 364 :k5322.

Frenck RW Jr, Nakhla I, Sultan Y, Bassily SB, Girgis YF, David J, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis. 2000;31(5):1134-8.

Nair BT, Simalti AK, Sharma S. Study comparing ceftriaxone with azithromycin for the treatment of uncomplicated typhoid fever in children of India. Ann Trop Med Public Health. 2017;10(1):205-10.

Aggarwal A, Ghosh A, Gomber S, Mitra M, Parikh AO. Efficacy and safety of azithromycin for uncomplicated typhoid fever: an open label non-comparative study. Indian Pediatr. 2011;48(7):553-6.

Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochia RL. Typhoid fever. The Lancet. 2015;385(9973):11136-45.

Frenck RW, Mansour A, Nakhla I, Sultan Y, Putnam S, Wierzba T, et al. Short-Course Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adolescents. Clin Infect Dis. 2004;38(7):951-7.

Girgis NI, Butler T, Frenck RW. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother. 1999;43(6):1441-4.

Chandey M, Multani AS. A comparative study of efficacy and safety of azithromycin and ofloxacin in uncomplicated typhoid Fever: a randomised, open labelled study. J Clin Diag Res. 2012;6(10):1736-9.

Smith M, Duong NM, Hoa NT, Ha HD, Diep TS, Day NP, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother. 1994;38:1716-20.

Tribble D, Girgis N, Habib N, Butler T. Efficacy of azithromycin for typhoid fever. Clin Infect Dis. 1995;21:1045-6.

Wallace MR, Yousif AA, Mahroos GA, Mapes T, Threlfall EJ, Rowe B, Hyams KC. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever. Eur J Clin Microbiol Infect Dis. 1994;12:907-10.

Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, et al. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multi drug resistant or nalidixic acid–resistant typhoid fever. Antimicrob Agents Chemother. 2000;44:1855-9.

Trivedi NA, Shah PC. A meta-analysis comparing the safety and efficacy of azithromycin over the alternate drugs used for treatment of uncomplicated enteric fever. J Post Graduate Med. 2012;58(2):112-8.